Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-197-3 | CAS number: 7446-11-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental start and completion dates: 15 March 2010 to 22 June 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- Ninth Addendum to the OECD Guidelines for the Testing of Chemicals, February 1998, adopted July 21, 1997, Guideline No. 476 "In vitro Mammalian Cell Gene Mutation test".
- Deviations:
- yes
- Remarks:
- Incorrect historical data dates entered in the protocol. Corrected in the report (2008-2009). No impact on study integrity.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- Commission Regulation (EC) No. 440/2008 B.17: "Mutagenicity - In vitro Mammalian Cell Gene Mutation Test", dated May 30, 2008.
- Deviations:
- yes
- Remarks:
- Incorrect historical data dates entered in the protocol. Corrected in the report (2008-2009). No impact on study integrity.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
Test material
- Reference substance name:
- Sodium sulphate
- EC Number:
- 231-820-9
- EC Name:
- Sodium sulphate
- Cas Number:
- 7757-82-6
- Molecular formula:
- H2O4S.2Na
- IUPAC Name:
- disodium sulfate
- Test material form:
- solid: crystalline
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source (i.e. manufacturer or supplier): Provided by the Sponsor, Dr. Wilhelm Rauch, Treuhandgemeinschaft, Deutscher Chemiefasererzeuger GmbH (TDC), Mainzer Landstrasse 55
60329 Frankfurt am Main, Germany.
- Lot/batch number of test material: 20091001
- Purity: > 99.5 %
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature
- Stability and homogeneity of the test material in the vehicle/solvent under test conditions (e.g. in the exposure medium) and during storage: Assumed stable for the duration of the study.
- Solubility and stability of the test material in the solvent/vehicle and the exposure medium: Soluble in deionised water up to the limit guideline concentration of 1420 µg/mL (i.e. ca. 10 mM). Assumed stable for the duration of the study.
- Reactivity of the test material with the incubation material used (e.g. plastic ware): None
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: Formulated to concentration in deionised water
OTHER SPECIFICS
- Other relevant information needed for characterising the tested material, e.g. if radiolabelled, adjustment of pH, osmolality and precipitate in the culture medium to which the test chemical is added: None
Method
- Target gene:
- Thymidine kinase (TK) locus of heterozygous L5178Y TK+/- cells
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: Autosomal thymidine kinase (TK) locus of heterozygous L5178Y TK+/- cells. Source - not stated
- Suitability of cells: Accepted cells for study use as per OECD guidance.
- Normal cell cycle time (negative control): Doubling time 10 - 12 hrs in stock cultures
For cell lines:
- Absence of Mycoplasma contamination: yes, before freezing, each batch was screened for mycoplasma contamination
- Number of passages if applicable: Not stated
- Methods for maintenance in cell culture:
- Doubling time: 10 - 12 hrs in stock cultures
- Modal number of chromosomes: The cells have a stable karyotype with a near diploid (40 ± 2) chromosome number
- Periodically checked for karyotype stability: yes, before freezing, each batch was checked for karyotype stability.
- Periodically ‘cleansed’ of spontaneous mutants: yes, prior to mutagenicity testing the amount of spontaneous mutants is reduced by growing cells for one day in RPMI 1640-HAT medium supplemented with: hypoxanthine 1.0×10-4 M, aminopterin 2.0×10-7M and thymidine 1.6×10-5 M. The incubation of the cells in HAT-medium is followed by a recovery period of 2 days in
RPMI 1640 medium containing: hypoxanthine 1.0×10-4 M and thymidine 1.6×10-5 M
After this incubation the L5178Y cells are returned to normal RPMI 1640 medium (complete culture medium).
MEDIA USED
- Type and composition of media:
Complete Culture Medium: RPMI 1640 medium (GIBCO, invitrogen) supplemented with 15 % horse serum (HS, GIBCO, invitrogen) (3 % HS during 4 hour treatment), 1% of 100 U/100 µg/mL Penicillin/Streptomycin, 220 µg/mL Sodium-Pyruvate, and 0.5 - 0.75 % Amphotericin used as
antifungal
Selective Medium: RPMI 1640 (complete culture medium) by addition of 5 µg/mL TFT.
CO2 concentration, humidity level, temperature: Plates were incubated at 37°± 1.5 °C in 4.5% CO2/95.5% in a humidified atmosphere. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: Phenobarbital/-naphthoflavone induced rat liver S9 was used as the metabolic activation system. The S9 was prepared from 8 - 12 weeks old male Wistar rats (Hsd Cpb: WU, Harlan Laboratories GmbH, 33178 Borchen, Germany) weight ca.. 220 - 320 g induced by intraperitoneal applications of 80 mg/kg b.w. phenobarbital (Desitin, 22335 Hamburg, Germany) and by peroral administrations of 80 mg/kg b.w. β-naphthoflavone (Sigma-Aldrich Chemie GmbH, 82024 Taufkirchen, Germany) each, on three consecutive days. Livers were prepared 24 hours after the last treatment.
- method of preparation of S9 mix: The S9 fractions were produced by dilution of the liver homogenate with a KCl solution (1+3 parts) followed by centrifugation at 9000 g. Aliquots of the supernatant were frozen and stored in ampoules at –80 °C. Small numbers of the ampoules were kept at –20 °C for up to one week. Each batch of S9 mix was routinely tested with 2-aminoanthracene as well as benzo(a)pyrene.
- concentration or volume of S9 mix and S9 in the final culture medium. The concentration in
the final test medium was 5% (v/v).
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): The protein concentration of the S9 preparation was 35.0 mg/mL (Lot. No.: 070110) in the
pre-experiment, 34.4 mg/mL (Lot. No.: 260210) in experiment I, and 35.0 mg/mL (Lot. No.: 160410) in experiment II. The stability of both positive control substances in solution is proven by the mutagenic response in the expected range. - Test concentrations with justification for top dose:
- The highest concentration (1420 µg/mL) was chosen based on the test item molecular weight which corresponds to a molar concentration of ca. 10 mM.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Deionised water
- Justification for choice of solvent/vehicle: The test item was soluble in deionised water up to the limit guideline concentration of 1420 µg/mL (Ca. 10 mM) based on the molecular weight.
- Justification for percentage of solvent in the final culture medium: The final concentration of deionised water in culture medium was 10 % (v/v). This is an acceptable as aqueous solvents should not generally exceed 10% (v/v) in the final treatment medium.
Controls
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Deionised water
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: Duplicate cultures
- Number of independent experiments: Two
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): Each well contained ca. 4×10-3 cells in selective medium with TFT. Viability (cloning efficiency) was determined by seeding about 2 cells per well (same medium without TFT).
- Test substance in deionised water added to culture medium.
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: Experiment 1: 4-hr treatment period with and without S9. Experiment 2: 24 hr treatment period (-S9) and 4 hr treatment (+S9).
- Harvest time after the end of treatment (sampling/recovery times): 10-15 days post expression period.
FOR GENE MUTATION:
- Expression time (cells in growth medium between treatment and selection): 48-hrs
- Selection time (if incubation with a selective agent): 10-15 days
- Fixation time (start of exposure up to fixation or harvest of cells): 10-15 days
- Method used: microwell plates for the mouse lymphoma assay.
- Selective agent used: Trifluorothymidine, 5 µg/mL TFT in RPMI 1640 (complete culture medium) for 10-15 days.
- Number of cells seeded and method to enumerate numbers of viable and mutants cells: Each well contained ca. 4×10-3 cells in selective medium with TFT. The viability (cloning efficiency) was determined by seeding ca. 2 cells/well into microtiter plates (same medium without TFT). Mutation rates are calculated from the number of mutant colonies corrected for cell survival (i.e. viable cells).
- Criteria for small (slow growing) and large (fast growing) colonies: Criteria to determine colony size were the absolute size of the colony (more than 1/3 of a well for large colonies) and the optical density of the colonies (the optical density of the small colonies is generally higher than the optical density of the large ones).
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: Relative total growth (RTG)
- Any supplementary information relevant to cytotoxicity: None
METHODS FOR MEASUREMENTS OF GENOTOXICIY:
When undertaken as part of a genotoxicity test battery, Sodium Sulphate did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation. - Rationale for test conditions:
- The highest concentration (1420 µg/mL) was chosen based on the test item molecular weight corresponding to a molar concentration of ca. 10 mM. The test item was soluble in deionised water up to the limit guideline concentration with duplicate cultures used per test concentration. In both main experiments the top five concentrations (88.8; 177.5; 355; 710; and 1420 µg/mL) with and without metabolic activation were assessed. No relevant cytotoxicity or precipitate was observed.
- Evaluation criteria:
- A test item is classified as mutagenic if the induced mutation frequency reproducibly
exceeds a threshold of 126 colonies per 10-6 cells above the corresponding solvent
control.
A relevant increase of the mutation frequency should be dose-dependent.
A mutagenic response is considered to be reproducible if it occurs in both parallel
cultures.
However, in the evaluation of the test results the historical variability of the mutation rates
in the solvent controls of this study are taken into consideration.
Results of test groups are generally rejected if the relative total growth is less than 10 % of
the vehicle control unless the exception criteria specified by the IWGT recommendations
are fulfilled.
Whenever a test item is considered mutagenic according to the above mentioned criteria,
the ratio of small versus large colonies is used to differentiate point mutations from
clastogenic effects. If the increase of the mutation frequency is accompanied by a
reproducible and dose dependent shift in the ratio of small versus large colonies
clastogenic effects are indicated. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose dependent increase of mutant frequencies using SYSTAT®11 (SYSTAT Software, Inc., 501, Canal Boulevard, Suite C, Richmond, CA 94804, USA) statistics software. The number of mutant colonies obtained for the groups treated with the test item was compared to the solvent control groups. A trend is judged as significant whenever the p-value (probability value) is below 0.05. Both biological relevance and statistical significance were considered together.
Results and discussion
Test results
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH & osmolality: Values similar to those of the vehicle control and therefore acceptable
- Water solubility: No, fully soluble to the guideline limit concentration of 10 mM.
- Precipitation and time of the determination: None
RANGE-FINDING/SCREENING STUDIES (if applicable): yes, a pre-test was performed to determine the concentration range of the mutagenicity experiments. Both, pH value and osmolarity were determined at the maximal test concentration and for the solvent control (+/-S9) and deemed acceptable. Based on results at least four adequate concentrations were chosen for the mutation experiments, only highest four tests concentrations were assessed.
STUDY RESULTS
- Concurrent vehicle negative and positive control data: Yes, deionised water (solvent control) and MMS (-S9) and CPA (+S9).
HISTORICAL CONTROL DATA (with ranges, means and standard deviation, and 95% control limits for the distribution as well as the number of data)
- Positive historical control data:
- Negative (solvent/vehicle) historical control data:
Any other information on results incl. tables
Table 2: Pre-experimental Toxicity data
|
|
| treatment | number of cells per mL | number of cells per mL | number of cells per mL | total | relative |
| conc. | S9 | period | found 4 h | found 24 h | found 48 h | suspension growth | suspension growth |
| Qg per mL | mix | h | after treatment | after treatment | after treatment | TSG | RSG |
Column | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
Solvent control with water |
| - | 4 | 308800 | 905600 | 1764800 | 17.3 | 100.0 |
Test item | 11.1 | - | 4 | 343600 | 1025200 | 2062000 | 20.5 | 118.9 |
Test item | 22.2 | - | 4 | 418000 | 906600 | 2102000 | 15.2 | 88.1 |
Test item | 44.4 | - | 4 | 350200 | 959000 | 1995000 | 18.2 | 105.6 |
Test item | 88.8 | - | 4 | 275400 | 889400 | 1626800 | 17.5 | 101.5 |
Test item | 177.5 | - | 4 | 341400 | 862800 | 1795000 | 15.1 | 87.7 |
Test item | 355.0 | - | 4 | 292400 | 787800 | 1664600 | 14.9 | 86.7 |
Test item | 710.0 | - | 4 | 320200 | 866000 | 1919400 | 17.3 | 100.3 |
Test item | 1420.0 | - | 4 | 296800 | 1056000 | 1702200 | 20.2 | 117.0 |
Solvent control with water |
| + | 4 | 384200 | 885200 | 2070000 | 15.9 | 100.0 |
Test item | 11.1 | + | 4 | 417000 | 973200 | 1953000 | 15.2 | 95.6 |
Test item | 22.2 | + | 4 | 414000 | 805000 | 2096000 | 13.6 | 85.5 |
Test item | 44.4 | + | 4 | 392200 | 960200 | 1910600 | 15.6 | 98.1 |
Test item | 88.8 | + | 4 | 339000 | 1063400 | 1886800 | 19.7 | 124.1 |
Test item | 177.5 | + | 4 | 361600 | 918000 | 1943800 | 16.4 | 103.5 |
Test item | 355.0 | + | 4 | 437000 | 920000 | 1932600 | 13.6 | 85.3 |
Test item | 710.0 | + | 4 | 421200 | 1099000 | 1896400 | 16.5 | 103.7 |
Test item | 1420.0 | + | 4 | 386400 | 1001000 | 1829400 | 15.8 | 99.4 |
Solvent control with water |
| - | 24 |
| 384400 | 1915600 | 24.5 | 100.0 |
Test item | 11.1 | - | 24 | 398200 | 1805800 | 24.0 | 97.7 | |
Test item | 22.2 | - | 24 | 377600 | 1841000 | 23.2 | 94.4 | |
Test item | 44.4 | - | 24 | 398000 | 1761200 | 23.4 | 95.2 | |
Test item | 88.8 | - | 24 | 379400 | 1742200 | 22.0 | 89.8 | |
Test item | 177.5 | - | 24 | 360600 | 1849600 | 22.2 | 90.6 | |
Test item | 355.0 | - | 24 | 384400 | 1740400 | 22.3 | 90.9 | |
Test item | 710.0 | - | 24 | 388600 | 1691800 | 21.9 | 89.3 | |
Test item | 1420.0 | - | 24 | 365800 | 1675200 | 20.4 | 83.2 |
Table 3: Main Experimental Toxicity data
|
|
| number of cells |
|
|
| ||
|
|
| per mL | total | relative | relative | ||
| conc. Qg | S9 | found 4 h | found 24 h | found 48 h | suspension | suspension | total |
| per mL | mix | after treatment | growth | growth | growth | ||
Column | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
Solvent control with water |
| - | 407000 | 775600 | 1993000 | 12.7 | 100.0 | 100.0 |
Pos. control with MMS | 19.5 | - | 429600 | 594400 | 1896400 | 8.7 | 69.1 | 41.0 |
Test item | 44.4 | - | 414800 | 551800 | culture was not continued# |
| ||
Test item | 88.8 | - | 557800 | 724400 | 2428000 | 10.5 | 83.0 | 86.7 |
Test item | 177.5 | - | 576400 | 734400 | 2316000 | 9.8 | 77.7 | 99.4 |
Test item | 355.0 | - | 411200 | 675200 | 1987400 | 10.9 | 85.9 | 101.1 |
Test item | 710.0 | - | 273200 | 559000 | 1957000 | 13.3 | 105.4 | 110.1 |
Test item | 1420.0 | - | 361200 | 538000 | 2446000 | 12.1 | 95.9 | 122.8 |
|
|
|
|
|
|
|
|
|
Solvent control with water |
| + | 360000 | 1037000 | 1500600 | 14.4 | 100.0 | 100.0 |
Pos. control with CPA | 3.0 | + | 299000 | 672000 | 1469400 | 11.0 | 76.4 | 52.4 |
Pos. control with CPA | 4.5 | + | 316600 | 712200 | 1308400 | 9.8 | 68.1 | 36.5 |
Test item | 44.4 | + | 409200 | 1024400 | culture was not continued# |
| ||
Test item | 88.8 | + | 456800 | 1078800 | 1412400 | 11.1 | 77.2 | 60.7 |
Test item | 177.5 | + | 345200 | 1036600 | 1349000 | 13.5 | 93.7 | 82.7 |
Test item | 355.0 | + | 376800 | 1291400 | 1336800 | 15.3 | 106.0 | 87.5 |
Test item | 710.0 | + | 357200 | 1108800 | 1411400 | 14.6 | 101.4 | 67.5 |
Test item | 1420.0 | + | 358800 | 1112800 | 1445400 | 14.9 | 103.7 | 105.7 |
# culture was not continued since only a minimum of four concentrations is required by the guidelines
Table 4: Summary of Results for Main Experiment.
|
|
| relative | mutant |
| relative | mutant |
|
| conc. Qg | S9 | total | colonies/ |
| total | colonies/ |
|
| per mL | mix | growth | 106 cells | threshold | growth | 106 cells | threshold |
Column | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
Experiment I / 4 h treatment |
| culture I | culture II | |||||
Solv. control with water |
| - | 100.0 | 164 | 290 | 100.0 | 162 | 288 |
Pos. control with MMS | 19.5 | - | 41.0 | 336 | 290 | 53.8 | 563 | 288 |
Test item | 44.4 | - | culture was not continued# | culture was not continued# | ||||
Test item | 88.8 | - | 86.7 | 139 | 290 | 146.1 | 208 | 288 |
Test item | 177.5 | - | 99.4 | 130 | 290 | 133.5 | 120 | 288 |
Test item | 355.0 | - | 101.1 | 156 | 290 | 130.4 | 191 | 288 |
Test item | 710.0 | - | 110.1 | 147 | 290 | 126.1 | 168 | 288 |
Test item | 1420.0 | - | 122.8 | 129 | 290 | 117.0 | 204 | 288 |
Experiment I / 4 h treatment |
| culture I | culture II | |||||
Solv. control with water |
| + | 100.0 | 168 | 294 | 100.0 | 162 | 288 |
Pos. control with CPA | 3.0 | + | 52.4 | 320 | 294 | 46.0 | 337 | 288 |
Pos. control with CPA | 4.5 | + | 36.5 | 467 | 294 | 26.4 | 517 | 288 |
Test item | 44.4 | + | culture was not continued# | culture was not continued# | ||||
Test item | 88.8 | + | 60.7 | 244 | 294 | 113.0 | 143 | 288 |
Test item | 177.5 | + | 82.7 | 221 | 294 | 78.8 | 142 | 288 |
Test item | 355.0 | + | 87.5 | 169 | 294 | 100.3 | 135 | 288 |
Test item | 710.0 | + | 67.5 | 230 | 294 | 105.8 | 149 | 288 |
Test item | 1420.0 | + | 105.7 | 142 | 294 | 74.9 | 131 | 288 |
Experiment II / 24 h treatment |
| culture I | culture II | |||||
Solv. control with water |
| - | 100.0 | 138 | 264 | 100.0 | 212 | 338 |
Pos. control with MMS | 13.0 | - | 24.5 | 426 | 264 | 12.9 | 391 | 338 |
Test item | 44.4 | - | culture was not continued# | culture was not continued# | ||||
Test item | 88.8 | - | 76.5 | 131 | 264 | 47.6 | 262 | 338 |
Test item | 177.5 | - | 84.6 | 98 | 264 | 64.6 | 253 | 338 |
Test item | 355.0 | - | 75.8 | 107 | 264 | 72.4 | 188 | 338 |
Test item | 710.0 | - | 48.7 | 159 | 264 | 68.7 | 159 | 338 |
Test item | 1420.0 | - | 91.9 | 141 | 264 | 59.9 | 214 | 338 |
Experiment II / 4 h treatment |
| culture I | culture II | |||||
Solv. control with water |
| + | 100.0 | 216 | 342 | 100.0 | 164 | 290 |
Pos. control with CPA | 3.0 | + | 51.1 | 262 | 342 | 36.3 | 181 | 290 |
Pos. control with CPA | 4.5 | + | 33.5 | 439 | 342 | 17.4 | 298 | 290 |
Test item | 44.4 | + | culture was not continued# | culture was not continued# | ||||
Test item | 88.8 | + | 90.8 | 123 | 342 | 144.2 | 66 | 290 |
Test item | 177.5 | + | 146.1 | 214 | 342 | 82.2 | 107 | 290 |
Test item | 355.0 | + | 97.5 | 163 | 342 | 147.1 | 102 | 290 |
Test item | 710.0 | + | 64.8 | 229 | 342 | 124.2 | 89 | 290 |
Test item | 1420.0 | + | 97.2 | 154 | 342 | 110.2 | 133 | 290 |
threshold = number of mutant colonies per 106 cells of each solvent control plus 126
Applicant's summary and conclusion
- Conclusions:
- The test item did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation. Therefore, Sodium Sulphate is considered to be non-mutagenic in this mouse lymphoma assay.
- Executive summary:
An OECD 476 study conducted to GLP was performed to investigate the potential of the test item, Sodium Sulphate, to induce mutations at the mouse lymphoma thymidine kinase locus using the cell line L5178Y. A pre-test was performed in the absence and presence of S9 to establish the concentration range for the mutagenicity experiments. No cytotoxicity was observed at 10 mM, the limit guideline concentration.
In both main assays, duplicate cultures were used per concentration with six concentrations tested. In the first experiment cells were treated for 4-hrs (+/-S9), in the second experiment cells were treated for 24-hrs (-S9) and for 4-hrs (+S9). The highest five concentrations (88.8, 177.5, 355, 710 and 1420 µg/mL) were selected for analysis based on the lack of observed cytotoxicity.
No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both experiments with no relevant shift of the ratio of small vs large colonies at any concentration. Appropriate negative (deionised water) and positive controls (MMS & CPH) were used, with the reference mutagens producing the expected inrease in mutant colonies confirming test sensitivity and validity.
Therefore, under the experimental conditions the test item, Sodium Sulphate, did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.